E Protein Transcription Factors Are Required for the Development of CD4+ Lineage T Cells

被引:83
作者
Jones-Mason, Mary Elizabeth [1 ]
Zhao, Xudong [3 ]
Kappes, Dietmar [6 ]
Lasorella, Anna [2 ,3 ,4 ]
Iavarone, Antonio [2 ,3 ,5 ]
Zhuang, Yuan [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[2] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA
[4] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA
[5] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA
[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
ZINC-FINGER; THYMOCYTE SELECTION; EXPRESSION; E2A; DIFFERENTIATION; GATA-3; THPOK; GENE; ID3; PROLIFERATION;
D O I
10.1016/j.immuni.2012.02.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The double-positive (DP) to single-positive (SP) transition during T cell development is initiated by downregulation of the E protein transcription factors HEB and E2A. Here, we have demonstrated that in addition to regulating the onset of this transition, HEB and E2A also play a separate role in CD4(+) lineage choice. Deletion of HEB and E2A in DP thymocytes specifically blocked the development of CD4(+) lineage T cells. Furthermore, deletion of the E protein inhibitors Id2 and Id3 allowed CD4(+) T cell development but blocked CD8(+) lineage development. Analysis of the CD4(+) lineage transcriptional regulators ThPOK and Gata3 placed HEB and E2A upstream of CD4(+) lineage specification. These studies identify an important role for E proteins in the activation of CD4(+) lineage differentiation as thymocytes undergo the DP to SP transition.
引用
收藏
页码:348 / 361
页数:14
相关论文
共 45 条
[1]
Development of Promyelocytic Zinc Finger and ThPOK-Expressing Innate γδ T Cells Is Controlled by Strength of TCR Signaling and Id3 [J].
Alonzo, Eric S. ;
Gottschalk, Rachel A. ;
Das, Joy ;
Egawa, Takeshi ;
Hobbs, Robin M. ;
Pandolfi, Pier Paolo ;
Pereira, Pablo ;
Nichols, Kim E. ;
Koretzky, Gary A. ;
Jordan, Martha S. ;
Sant'Angelo, Derek B. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (03) :1268-1279
[2]
Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade [J].
Bain, G ;
Cravatt, CB ;
Loomans, C ;
Alberola-Ila, J ;
Hedrick, SM ;
Murre, C .
NATURE IMMUNOLOGY, 2001, 2 (02) :165-171
[3]
Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[4]
THE PROTEIN ID - A NEGATIVE REGULATOR OF HELIX-LOOP-HELIX DNA-BINDING PROTEINS [J].
BENEZRA, R ;
DAVIS, RL ;
LOCKSHON, D ;
TURNER, DL ;
WEINTRAUB, H .
CELL, 1990, 61 (01) :49-59
[5]
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes [J].
Bouillet, P ;
Purton, JF ;
Godfrey, DI ;
Zhang, LC ;
Coultas, L ;
Puthalakath, H ;
Pellegrini, M ;
Cory, S ;
Adams, JM ;
Strasser, A .
NATURE, 2002, 415 (6874) :922-926
[6]
Coreceptor reversal in the thymus:: Signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells [J].
Brugnera, E ;
Bhandoola, A ;
Cibotti, R ;
Yu, Q ;
Guinter, TI ;
Yamashita, Y ;
Sharrow, SO ;
Singer, A .
IMMUNITY, 2000, 13 (01) :59-71
[7]
Decision checkpoints in the thymus [J].
Carpenter, Andrea C. ;
Bosselut, Remy .
NATURE IMMUNOLOGY, 2010, 11 (08) :666-673
[8]
RUNX proteins in transcription factor networks that regulate T-cell lineage choice [J].
Collins, Amelie ;
Littman, Dan R. ;
Taniuchi, Ichiro .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (02) :106-115
[9]
The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells [J].
Egawa, Takeshi ;
Tillman, Robert E. ;
Naoe, Yoshinori ;
Taniuchi, Ichiro ;
Littman, Dan R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1945-1957
[10]
Early thymocyte development is regulated by modulation of E2A protein activity [J].
Engel, I ;
Johns, C ;
Bain, G ;
Rivera, RR ;
Murre, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :733-745